Skip to main content

Tilray Brands, Inc. Stock Forecast and Price Prediction

A 12-month price target of $7.25 has been set by the 15 analysts covering Tilray Brands Inc. (NASDAQ:TLRY), with the highest estimate being $23.00 and the lowest being $4.50. The price has risen from a consensus expectation of $4.54 by 59.69 percent.

Earnings Estimate TLRY

There are now five Wall Street analysts who track NASDAQ: TLRY shares that have urged investors to hold on to their positions. According to the five experts surveyed, TLRY should be purchased at a 20% discount, with 0% proposing a buy, 60% keeping it on hold, 0% recommending a sell, and 20% strongly selling it. In addition, one expert strongly recommends that TLRY be sold. According to analysts, it is one of the best stocks to buy now.

Revenue Estimate TLRYRevenue Estimate TLRY

Tilray Brands Inc. Stock Forecast: A look at the company’s projected earnings for 2022-2024.

Tilray Brands Inc.
Source: Getty Images

TLRY is Tilray’s stock symbol. A 28.13 percent forecasted profit growth rate for the US Drug Manufacturers – Specialty & Generic sector is not expected by Tilray Brands Inc. At the same time, the US market’s average predicted profit growth rate of 15.78 percent is not likely to be exceeded.

Another way of putting it would be to say that for 2022, six Wall Street analysts predict that the business will earn an average of $84,000,000. That’s a reduction from the worst-case scenario’s $144,335,455 and the best-case scenario’s $29,862,508 estimate. According to nine Wall Street analysts, the lowest TLRY earnings prognosis is -$164,243,793, and the highest TLRY profits expectation is $44,793,762.

Profits are expected to be $59.725,016 for the year 2024; the lowest estimate is -$89,588,524, while the highest estimate is $19,908,339.

Tilray Brands Inc. Stock Forecast: Projected company earnings for 2022-2024.

Tilray Brands Inc. Stock Forecast
Source: Getty Images

There is a stock market for (TLRY) on the NYSE. Thus, Tilray Brands Inc. does not anticipate outperforming the average projected revenue growth rate of 8.16 percent for the US Drug Manufacturers – Specialty and Generic sector. The standard predicted revenue growth rate is 9.2 percent for the US market. Accordingly, Tilray Brands Inc. anticipates sales of N/A in 2022.

By Wall Street estimates, revenues for this firm are expected to reach $320,285,350,753 in 2022, with a low estimate of $301,416.855.95 and a high estimate of $351,481. TLRY’s revenue in 2023 is expected to range from $327.890 billion to $428.372.697.280 billion, with an average estimate of $359.7 billion.

While TLRY is anticipated to bring in $392 million in sales in 2024, the lowest revenue prediction is $346 million, and the highest is $468 million. TLRY is predicted to bring in $392 million in sales in 2024, the lowest is $346 million, and the most is $468 million.

Tailor Brands Inc. Stock Forecast: ROA EPS e ROE 2022-2025.

Tilray Brands Inc. Stock NASDAQ
Source: Getty Images       

ROA is estimated to be 1.88 percent, lower than the industry average ROA expectations of 17.54 percent (NASDAQ: TLRY).

The company’s stock symbol is “TLRY.” Tilray Brands Inc. EPS is N/A at present. TLRY’s 2022 EPS is anticipated to be -$0.17 on average, with the lowest EPS forecast to be -$0.29, and the highest EPS expected to be -$0.06.

It is predicted that TLRY’s earnings per stock (EPS) will be -$0.19 by 2023, with the lowest EPS estimate being -$0.33 and the highest estimate being $0.09. There is a wide range of -$0.18 to -$0.04, which anticipated the EPS decline for TLRY in 2024. NASDAQ: TLRY has a poor projected return on equity (ROE) of 2.37 percent.

Tilray Brands, Inc. Stock Price Predictions: Monthly Projections

Tilray Brands Inc. Forecast
Source: Getty Images

Tilray’s June 2022 stock price forecast

This month’s peak price should be $4.79878. The highest possible price is $5.49, while the lowest possible price is $4.25.

The predicted price of Tilray’s stock in July 2022

In the best-case scenario, a price target of $5.99368 is set for this month. The highest possible price is $6.91, while the lowest possible price is $5.63.

The Tilray stock forecast for August 2022

This month’s high is $6.47916, which is the optimal price. The most reasonable fee is $7.47, while the least likely is $5.25.

The September 2022 Tilray stock prediction

As for this month, a price goal of $6.40141 is reasonable. The highest goal price is $7.11, and the lowest target price is $4.94.”

The October 2022 Tilray stock prediction

This month’s price objective is $4.59622, and a drop is expected. The maximum and lowest price targets, on the other hand, are $5.59 and $3.53, respectively.

Tilray’s stock price forecast for November 2022

The optimum price objective is $4.65137, with a projected gain this month. Therefore, $5.47 is the highest price objective, while $4.16 is the lowest.

Tilray’s stock is expected to rise in December 2022.

The uptrend prediction has a price objective of $5.92119.

There is a maximum goal price of $7.22 and a minimum target price of $5.28.

A look at what some analysts think about the future of Tilray Brands, Inc.

analysts
Source: Getty Images

Tilray is followed by three analysts with a neutral view but optimistic price targets. At $6.42 as of this writing, the current price is predicted to grow to $7.96 this week, a gain of almost 20%.

According to a Haywood analyst with a “hold” recommendation, it is expected that Tilray will be worth $7.50 in the next year. Gilmer had adjusted the EBITDA of $11.4 million for the third quarter, lower than his estimates.

Tilray’s principal source of near-term revenue growth is the Canadian cannabis market, which he remains cautious about. In light of these findings, he has decided to hold off on becoming a full-blown bull until he sees more evidence of the company’s ability to develop at an accelerated pace.

The “oversupplied” Canadian recreational marijuana market is a problem for Tilray, according to Zuanic.

Tilray’s long-term market stock predictions will continue to be impacted by the Canadian cannabis business, according to a Benchmark Co. analyst. Instead of the cannabis business, he expects the company to grow in non-cannabis areas like alcohol and wellness. Despite the Aphria deal, Hickey was skeptical about cost reduction.

The post Tilray Brands, Inc. Stock Forecast and Price Prediction appeared first on Best Stocks.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.